IP Library Granted Patent US 7,470,532
Granted Patent B2
US 7,470,532 · App. 11/253,882 · Granted Dec 30, 2008

Patent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,470,532
App. No.
11/253,882
Granted
Dec 30, 2008
Kind
B2
Abstract

The present invention relates to a fungal C 16/18 fatty acid elongase that is able to catalyze the conversion of palmitate (16:0) to stearic acid (18:0). Specifically, the nucleotide sequence of a Mortierella alpina C 16/18 fatty acid elongase is provided (designated as “ELO3”). Methods of increasing microbial oil production, increasing carbon flux into the polyunsaturated fatty acid biosynthetic pathway and increasing the content of polyunsaturated fatty acids by over-expression of the C 16/18 fatty acid elongase are described herein. Most desirably, the substrate specificity of the instant ELO3 will be particularly useful to enable accumulation of long-chain polyunsaturated fatty acids in oleaginous yeast, such as Yarrowia lipolytica.

Claims (13)

1. An isolated nucleic acid molecule encoding a C 16/18 fatty acid elongase enzyme, selected from the group consisting of:

(a) an isolated nucleic acid molecule encoding the amino acid sequence as set forth in SEQ ID NO:2 and

(b) an isolated nucleic acid molecule that hybridizes with (a) under the following hybridization conditions: 0.1×SSC, 0.1% SDS, 65° C. and washed with 2×SSC, 0.1% SDS followed by 0.1×SSC, 0.1% SDS; or,

an isolated nucleic acid molecule that is completely complementary to (a) or (b).

2. The isolated nucleic acid molecule of claim 1 as set forth in SEQ ID NO: 1.

3. An isolated nucleic acid molecule comprising a first nucleotide sequence encoding a C 16/18 fatty acid elongase enzyme of at least 275 amino acids that has at least 95% identity based on the BLAST method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:2;

or a second nucleotide sequence comprising the complement of the first nucleotide sequence.

4. A chimeric gene comprising the isolated nucleic acid molecule of claim 1 operably linked to suitable regulatory sequences.

5. An isolated host cell comprising the isolated nucleic acid molecule of claim 1 .

6. The isolated host cell of claim 5 selected from the group consisting of algae, bacteria, fungi and yeast.

7. The transformed host cell of claim 6 wherein the yeast is an oleaginous yeast.

8. The transformed host cell of claim 7 wherein the oleaginous yeast cell is selected from the group consisting of: Yarrowia, Candida,Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.

9. The transformed host cell of claim 8 wherein the host cell is Yarrowia lipolytica.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2006
From: MACOOL, DANIEL JOSEPH; ZHU, QUINN QUN; XUE, ZHIXIONG
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 017001/0058 →